These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 21173604

  • 1. Neoadjuvant and adjuvant strategies in renal cell carcinoma: more questions than answers.
    Homicsko K, Berthold DR.
    Anticancer Drugs; 2011 Jan; 22 Suppl 1():S4-8. PubMed ID: 21173604
    [Abstract] [Full Text] [Related]

  • 2. Vaccine therapy in patients with renal cell carcinoma.
    Van Poppel H, Joniau S, Van Gool SW.
    Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant autologous tumour cell-lysate vaccine versus no adjuvant treatment in patients with M0 renal cell carcinoma after radical nephrectomy: 3-year interim analysis of a German multicentre phase-III trial.
    Doehn Ch, Richter A, Lehmacher W, Jocham D.
    Folia Biol (Praha); 2003 Jun; 49(2):69-73. PubMed ID: 12779015
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP.
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and treatment of renal cell carcinoma in children: a report from the Polish pediatric rare tumor study group.
    Stachowicz-Stencel T, Bien E, Balcerska A, Godzinski J, Synakiewicz A, Perek-Polnik M, Kurylak A, Pietras W, Kuzmicz M, Mizia-Malarz A, Rybczynska A, Nurzynska-Flak J.
    Klin Padiatr; 2011 May; 223(3):138-41. PubMed ID: 21509711
    [Abstract] [Full Text] [Related]

  • 6. Targeted therapy of renal cell cancer.
    Wysocki PJ, Zolnierek J, Szczylik C, Mackiewicz A.
    Curr Opin Investig Drugs; 2008 Jun; 9(6):570-5. PubMed ID: 18516756
    [Abstract] [Full Text] [Related]

  • 7. Neoadjuvant and adjuvant treatment of renal cell carcinoma.
    Thillai K, Allan S, Powles T, Rudman S, Chowdhury S.
    Expert Rev Anticancer Ther; 2012 Jun; 12(6):765-76. PubMed ID: 22716493
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant therapy of renal cell carcinoma patients with an autologous tumor cell lysate vaccine: a 5-year follow-up analysis.
    Repmann R, Goldschmidt AJ, Richter A.
    Anticancer Res; 2003 Jun; 23(2A):969-74. PubMed ID: 12820332
    [Abstract] [Full Text] [Related]

  • 9. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H, Semler O, Bürger D, Bode U, Flentje M, Göbel U, Gutjahr P, Leuschner I, Maass E, Niggli F, Scheel-Walter HG, Stöckle M, Thüroff JW, Tröger J, Weirich A, von Schweinitz D, Zoubek A, Graf N.
    Klin Padiatr; 2004 Jun; 216(3):132-40. PubMed ID: 15175957
    [Abstract] [Full Text] [Related]

  • 10. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.
    Wood CG.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 2):697s-702s. PubMed ID: 17255296
    [Abstract] [Full Text] [Related]

  • 11. Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?
    Brookman-May S, May M, Gilfrich C, Wieland WF, Burger M.
    Expert Rev Anticancer Ther; 2010 Jun 15; 10(6):813-23. PubMed ID: 20553207
    [Abstract] [Full Text] [Related]

  • 12. Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials.
    Bex A, Jonasch E, Kirkali Z, Mejean A, Mulders P, Oudard S, Patard JJ, Powles T, van Poppel H, Wood CG.
    Eur Urol; 2010 Dec 15; 58(6):819-28. PubMed ID: 20828919
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant therapy for renal cell carcinoma.
    Jacobsohn KM, Wood CG.
    Semin Oncol; 2006 Oct 15; 33(5):576-82. PubMed ID: 17045086
    [Abstract] [Full Text] [Related]

  • 14. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS.
    J Urol; 2005 Jun 15; 173(6):1853-62. PubMed ID: 15879764
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant and neoadjuvant therapy for renal cell carcinoma: a survey of the Society of Urologic Oncology.
    Tobert CM, Uzzo RG, Wood CG, Lane BR.
    Urol Oncol; 2013 Oct 15; 31(7):1316-20. PubMed ID: 22264501
    [Abstract] [Full Text] [Related]

  • 16. Advances in immune-based therapies of renal cell carcinoma.
    Lam JS, Belldegrun AS, Figlin RA.
    Expert Rev Anticancer Ther; 2004 Dec 15; 4(6):1081-96. PubMed ID: 15606335
    [Abstract] [Full Text] [Related]

  • 17. [Is there an indication for neoadjuvant or adjuvant systemic therapy in renal cell cancer?].
    Doehn C, Merseburger AS, Jocham D, Kuczyk MA.
    Urologe A; 2007 Oct 15; 46(10):1371-2, 1374, 1376-8. PubMed ID: 17805507
    [Abstract] [Full Text] [Related]

  • 18. ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease.
    Patard JJ, Pignot G, Escudier B, Eisen T, Bex A, Sternberg C, Rini B, Roigas J, Choueiri T, Bukowski R, Motzer R, Kirkali Z, Mulders P, Bellmunt J.
    Eur Urol; 2011 Oct 15; 60(4):684-90. PubMed ID: 21704448
    [Abstract] [Full Text] [Related]

  • 19. The role of cytoreductive nephrectomy in the era of molecular targeted therapy.
    Polcari AJ, Gorbonos A, Milner JE, Flanigan RC.
    Int J Urol; 2009 Mar 15; 16(3):227-33. PubMed ID: 19207114
    [Abstract] [Full Text] [Related]

  • 20. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
    Karam JA, Wood CG.
    Hematol Oncol Clin North Am; 2011 Aug 15; 25(4):753-64. PubMed ID: 21763966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.